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POTENTIATION OF ANTICOAGULANT TOXICITY TO Rattus rattus BY TWO 
NON-STEROID ANTI-INFLAMMATORY DRUGS 
SHAKUNTHALA SRIDHARA and T. R. KRISHNAMURTHY, AICRP on Rodent Control College of Basic 
Sciences and Humanities, University of Agricultural Sciences, G.K. V.K, Bangalore, 560 065. India ' 
ABSTRACT: In view of resistance reported to have developed towards second generation anticoagulants and the problem of 
bait shyness and neophobia when acute rodenticides are used it becomes imperative that methods be evolved to oven:ome these 
problems. Attempts to potentiate anticoagulants for effective rodent control is a new concept with very few studies. Experi-
me~IS using rn:o non-steroid ~ti-inflam~atory, drugs namely ibu~rofen ~d phenylbutazone at 80 mg/kg and SO mg/kg body 
we1?~t respecnvely to potennate the action of two second generanon anbcoagulants, brodifacoum and bromadiolone yielded 
JX?S1t1ve results for Rattus rattus. The drugs reduced the lethal dose required for 100% mortality as well as days to death. Field 
trials confirmed laboratory findings. 
INTRODUCTION 
The concept of total rodent eradication still remains a 
dream with acute rodenticides like zinc phosphide leaving 
bait shy populations and anticoagulants resulting in resistant 
strains. Even the second generation anticoagulants are re-
ported to have led to development of resistance (Rowe et al. 
1981 ). This new trend makes it invitable to potentiate second 
generation anticoagulants to ensure complete mortalities 
quickly. Certain drugs are known to interact with oral antico-
agulants by a variety of mechanisms such as altered absorp-
tion, binding and/or meiabolism of protein. The action of 
phenylbutazone in potentiating anticoagulant effect is well 
known (Lewis et al. 1974). Hence experiments were design-
ed to study the possibility of potentiation of two second gen-
eration anticoagulants viz bromadiolone (C30 H23 Br 04), 
3-(4 hydroxy-3- coumarinyl), 3 phenyl-1-(4 bromo-p-biphe-
nyl) propanol) also known as 'Supercaid' and 'Maki' and 
brodifacoum (C31 H230J Br), (-(3-(4 bromobiphenyl-4-yl) -
1,2,3,4-tetra hydronaphthyl-I-yl)-4-hydroxy coumarin) by 
two non-steroidal, anti-inflammatory drugs (NSAIDs) 
namely phenylbutazone and ibuprofen. 
METHODS 
The experimental procedure consisted of five steps: First 
to establish toxicity of wax cakes and technical grade con-
centration of bromadiolone and brodifacoum to Raltus rattus. 
Secondly to establish the 10lerance limits of R. rallus to 
ibuprofen and phenylbutazone. Third 10 evaluate the poten-
tiation of wax cakes ofbrodifacoum and bromadiolone by the 
two drugs. Fourth to test the potentiation of technical grade 
concen-trations of the two rodenticides. Finally field evalua-
tion of wax cakes mixed with the two drugs was carried out 
All experi-ments were conducted on wild, field caught Rattus 
rattus. 
Bromadiolone Toxicity 
No choice test-Rais (N = 12) after being acclimated to 
labora10ry conditions were weighed and caged individually. 
Each rat was exposed to a single wax cake (20g) containing 
0.005% rodenticide for 24 hrs and its intake recorded. There-
after the subjects were fed standard rat feed and observed for 
poison ingested, days to death and mortality for 3 weeks. A 
similar no choice test on 12 subjects was conducted but by 
exposing them to the cake for 48 hrs. Data on poison in-
gested, mortality and days to death were recorded over 3 
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weeks. 
Choice test-Two batches of rats (N=12) were exposed 
to wax cakes and non-poisonous ragi bait (Eleusine coracana) 
+ 10% growidnut oil (Arachis hypogea) for 24 and 48 hrs re-
spectively. At the end of exposure period, data on the amount 
of ragi bait and poison cake consumed, days to death and 
mortality were documented. 
Oral toxicity studies-After acclimation to laboratory 
conditions R. rattus with equal rep~nlation of the two sexes 
were weighed and caged individually and starved overnight 
Calculated amount of technical grade (99.99%) bromadiolone, 
were dissolved in known quantities of polyethylene glycol to 
get the required percent concentration. Depending on the 
weight of the animal, calculated amounts of bromadiolone 
was injected directly in10 the stomach of 20 animals by oral 
intubation in order to get 1, 2, 3, 4 and S mg poison,Acg body 
weight Six hours lat.er the rats were given standard rat feed 
and were maintained for 3 weeks on the same feed during 
which time the days to death and mortality were recorded. 
Using probit analysis (Litchfield and Wilcoxin 1949), the 
LDso values were calculated. 
Brodifacoum Toxicity 
No choice and choice tests were carried out on 
brodifacoum wax cakes (0.005%). The procedure followed, 
being similar to bromadiolone evaluation. 
Acute oral toxicity studies-Five concentrations of tech-
nical grade brodifacoum (99.99%) namely 0.5, 1.0, 1.5, 2.0 
and 2.5 mg/kg were employed for detennining LDso values. 
The experimental details were similar 10 bromadiolone oral 
toxicity tests. 
Tolerance limit for ibuprofen and phenylbutazone 
Ibuprofen-Four batches of RJatlus comprising of 10 
rats each (5 males and S females) were acclimated and starved 
overnight prior to the test To one batch of rats Sml ibuprofen 
(Fenlong, Sol Phannaceuticals Ltd, Hyderabad) caliberated 
10 contain 20 mg/kg body weight was dire.ctly fed in10 the 
s10mach by oral intubation. Similarly the remaining three 
groups of rats were given dosages of 40 mg/kg, 80 mg/kg and 
100 mg/kg. Twelve hours later experimental rats were fed 
nonnally and were kept under observation for monality for 
three days. 
Phenylbutazone-Forty rats divided into four batches of 
10 each were subcutaneously injected with calibrated doses 
212 
of 50 mg/kg, 100 mg/kg, 150 mg/kg and 200 mg/kg after 
starving them overnight. Twelve hrs after ireatment the rats 
were put on regular diet for 3 days and mortalities recorded. 
Potenliation of wax cakes of bromadiolone and 
brodifacoum by ibuprofen and phenylbutawne 
Bromadiolone-No choice test-Twenty four R.ranus 
were individually caged and starved overnight. One batch of 
12 rats was fed ibuprofen at 80 mg/kg body weight by oral 
inwbation and the second batch subcutaneously injected with 
50 mg/kg phenylbuiazone. In the afternoon all !he rats were 
given one bromadiolone wax cake (20 mg) for 24 hours after 
which the rats were fed normally and kept under observation 
for mortality. 
Choice test- The acclimated rats, numbering 24, were 
starved overnight. Next morning they were divided into two 
batches: one batch was injected wilh 50 mg/kg phenyl-
butazone and the other inrubated wilh 80 mg/kg body weight 
with ibuprofen. Both groups were exposed to a choice test of 
30g each of mixed cereals and standard rat feed and 20g 
bromadiolone wax cake contzaining 0.005% rodenticide for 
24 hrs. Later !hey were mainlllined on standard rat feed and 
observed for mortality. 
Brodifacourn-Evaluation of potentialion of brodifa. 
coum wax cakes (0.005%) was done by carrying out no 
choice and choice tests as described for bromadiolone. In all 
!he tes1S quantity of wax cake consumed was weighed and con· 
vellal tog <XlllSllllle®OOg body weight for comparirons. 
Potentialion of technical grade anticoagulants. 
Bromadiolone-A total of 20 R.ranus were acclimated 
to laboratory, starved overnight and weighed in the morning. 
To one batch, ibuprofen at 80 mg/kg was administered by 
stomach intubation and to the second batch of 10 rats 
phenylbutazone at 50 mg/kg was injected subcutaneously. In 
the afternoon all the 20 animals were administered 
bromodiolone dissolved in polyethylene glycol at 2 mg/kg. 
After four hours they were fed standard rat feed and observed 
for percent mortality and duration to dealh. 
Brodifacoum-To ibuprofen and phenylbutazone 
administtated rats as in the previous experiments. I mg 
brodifacoum/kg was stomach fed by intubation followed by 
observations on mortality and days to dealh. 
Field Evaluation of potentiated anticoagulants 
Nine poultty sheds measuring 100' x 40' and hous-
ing 2,000 chicks each at !he Central Poultry Breeding and 
Research Institute, at Hesaraghatta, 25 km from Bangalore 
were selected for evaluating the potentiated anticoagulant ac-
tivity of bromadiolone and brodifacourn. The sheds were 
infested with only Rattus rattus. The population in each shed 
was estimated by surplus baiting method (Barnett et al.1951) 
using poultry feed. The rates of bait consumption per shed are 
presented in Table I. Based on earlier observations that a 
single R .rattus weighs an average of 11 Og and consumes a 
mean of 14g poultry feed (Krishnamurlhy 1990) !he number 
of rats present in each shed and lheir total weights were ex· 
trapolated (Table.I). The tolerable and effective dosages of 
ibuprofen and phenylbutazone for the rat population of each 
shed was calculated as in Table l. The evaluation of their 
potentiation was carried out in two sets of experiments. In !he 
fust set of tests, wax cakes of brodifacoum and bromadiolone 
were powdered and mixed wilh calculated amounts of 
ibuprofen and phenylbutazone separately. Thus shed l was 
exposed to brodifacoum + ibuprofen, shed 2 to brodifacoum 
+ phenylbutazone, shed 3 to bromadiolone + ibuprofen, shed 
4 to bromadiolone + phenylbutazone at the dosages presented 
in Table 1. Each shed had 10 bait points. Similarly sheds 5 to 
8 were exposed to 10 bait stations of poultty containing the 
two drugs as calibrated in Table 1. In sheds 5 and 6 
brodifacourn cake was placed beside each bait container and 
in sheds 7 and 8 bromadiolone cakes were placed similarly. 
The 91h shed served as control. After 48 hrs of exposure !he 
baits were removed and population estimates carried out by 
surplus baiting. The difference in the bait consumed prior to 
and after treaunent were converted into percent reduction in 
bait consumed and tabulated (Table 2). The significance of 
potenliation of bromadiolone and brodifacourn by ibuprofen 
Table 1. Details of rodenticide and calibrated dosages of anti-inllammatory drugs evaluated in poultry sheds. 
Equivalent rats Total wL of rat 
Kg bait calculated at (kg/shed) 
Shed No. consumed 14g/rat {@llOg/rat) Rodenticide plus calibrated dosage of NSAIDs 
l 1.331 95 10.45 25g brodifacoum•+38.36 ml IP b 
2 1.148 82 9.05 25g brodifacoum•+2.25 ml PB c 
3 1.512 108 11.88 25g bromadiolone•+9.5 ml IP 
4 1.064 76 8.36 25g bromadiolone + 2.9 ml PB 
5 0.742 53 5.83 0.742 kg poultry feed+ 4.66 ml IP 
6 1.092 78 8.58 1.092 kg poultry feed + 2.15 ml PB 
7 1.204 86 9.46 1.204 kg poultry feed + 7.57 ml IP 
8 1.61 115 12.65 l.61 kg poultry feed+ 3.16 ml PB 
9 1.274 91 10.01 1.274 kg poultry feed 
"Powdered brodifacoum and bromadiolone 
b IP= Ibuprofen at 80 mg/kg. 
"PB = Phenylbutawne at 50 mg/kg. 
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Table 2. Field Trials of anticoagulants potentiated by ibuprofen 
and phenylbutazone. 
Treatment 
% Reduction in 
bait consumed 
Brodifacoum + lbuprof en 72.5 
Brodifacoum + Phenylbutazone 85.S 
Bromadiolone + Ibuprofen 55.6 
Bromadiolone + Phenylbutazone 62.7 
Brodifacown + Ibuprofen in poultry feed 87.5 
Brodifacoum + Phenylbutazone in poultry feed 91.7 
Bromadiolone +Ibuprofen in poultry feed 75.6 
Bromadiolone + Phenylbutazone in poultry feed 83.3 
Control 9.4 
ANOV A table for above data. 
Mean 
Source of variation Of square F. ratio 
Replicates 4 55.09 2.33• 
Rodenticides (A) 1 2250.00 95.16b 
Potentiating agent (B) 1 640.03 27.07b 
mixed in feed 
Potentiating agent mixed 1 2387.05 100.9Sh 
with wax powder (C) 
AxB l 3.59 o.1s• 
Axe 1 235.23 9.95b 
BxC 1 42.00 1.781 
AxBxC l 55.22 2.34• 
ERROR 28 23.64 
•Not significant 
bVery highly significant (p<0.001) 
and phenylbutazone was arrived at by applying Duncan's 
Multiple Range test (Fedrer 1963). 
RESULTS 
Toxicity of bromadiolone and brodifacoum 
Bromadiolone-In no choice test, 24 hrs exposure of 
bromadiolone cake (0.005%) resulted in mean 70% mortality 
of R.rattus with females significantly ingesting more of wax 
cake than males and succumbing 80% as compared to 60% 
mortality of males. Forty eight hrs exposure to the poison 
resulted in 90% mortality in males. Females ingested more 
poison and succwnbed 100%. Days to death was an average 
of 7.9 days for 24 hrs poisoned rats and S.78 days for 48 hrs 
fed rats. 
In choice tests only 60% of both sexes died in 7 .8 days 
when bromadiolone cake was fed for 24 hrs. Forty eight 
hours exposure to the same resulted in 100 percent mortality 
in 6.7 days. 
Oral toxicity experiments demonstrated LDso value of bro-
madiolone as 22 mg/kg with a confidence limit of 1.1-4.4 mg/ 
kg for males and 1.75 mg/kg for females with confidence 
limits of 0.76-4.02 mg/kg. 
Brodifacoum-Both the sexes succumbed 100% to 
brodifacoum wax cakes in both choice and no choice tests as 
well as 24 and 48 holll'S exposure. Death occum:d faster in 
no choice test ie., 4.6 days and 3.5 days in 24 and 48 hrs 
exposure respectively. whereas in choice tests death occurred 
in 6.7 and 6.1 days for 24 and 48 hrs exposed rats respec-
tively. Comparatively lower amount of poison was ingested 
during choice tesc i.e., 3.31 mg/kg (24 hrs) and 4.39 mg/kg 
(48 hrs) than during no choice test i.e., 6.5 mg/kg and 7.98 
mg/kg for 24 and 48 hrs poisoned rats respectively 
Experiments on oral toxicity established LDso value of 
brodifacown as 0.9 mg/kg for male rats with confidence 
limits of 0.276-2.923 mg/kg and for females 0.7 mg/kg with 
confidence limits of0.165-2.975 mg/kg. 
Tolerance limits of R.rattus 
to ibuprofen and phenylbutazone 
Ibuprofen-Rats treated with ibuprofen at 20 mg/kg, 
40 mg/kg, 60 mg/kg and 80 mg/kg did not die even after 72 
hrs but those which ingested 100 mg/kg died within 24 hrs 
suggesting the tolerance limit to be 80 mg/kg. 
Phenylbutazone at 100 mg/kg, 150 mg/kg and 200 mg/ 
kg induced 100 percent mortality after 24, 2 and half an hour 
respectively. Therefore 50 mg/kg of phenylbutazone seems 
to be the tolerance limit for R.raJtus. 
Potentiation of anticoagulant 
activity of wax cakes by the two drugs 
Bromadiolone-Rats fed with 80 mg/kg ibuprofen fol-
lowed by exposure to bromadiolone wax cake for 24 hours 
succumb within 24 hours compared to 100% mortality and 
6.7 days to death when only bromadiolone cake was given 
that too for 48 hrs. Even the amount of poison ingested, 
2.52 mg/kg in choice test and 2.49 mg/kg in no choice test, 
was less when compared to rats fed only on bromadiolone 
(6.13 mg/kg), 
Subcutaneous injection of phenylbutazone at 50 mg/kg 
to bromadiolone poisoned rats also resulted in 100% over-
night mortality in both no choice and choice tests compared 
to 6. 7 days when rats were exposed for 48 hrs to 
bromadiolone cakes. Even the poison ingested was only 1.25 
mgJkg in choice test and 1.73 mg/kg in no choice~ (fable 3). 
Brodifacoum - The potentiation of brodifacoum wax 
cakes by the two NSAIDs was similar to that of bro-
macliolone. Ibuprofen + brodifacoum wax cake fed rats suc-
cumbed 100% overnight (Table 4) compared to 4.6 and 3.5 
days taken by rats fed only on brodifacoum cakes for 24 and 
48 hrs respectively in no choice tests and 6.7 and 6.1 days 
taken by rats tested in choice tests after 24 and 48 hrs expo-
sure. The poison ingested was similarly far less in ibuprofen 
treated rats in choice test and no choice test compared to rats 
poisoned with only brodifacum cake. 
Phenylbutazone too potentiated the action of brodi-
facoum wax cakes by inducing death overnight and at con-
centrations far below that of rats exposed only to cakes both 
in no choice and choice tests (Table 4). 
Duncan's Multiple Range test (Fedrer 1963) revealed 
following significant differences between bromodiolone 
cake and brodif acoum cake poisoned rats and those rats 
whose poison action was potentiated by ibuprofen and 
phenylbutazone: (1) Between bromadiolone and brodi-
facoum, the later was more potent as seen by lesser amounts 
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Table 3. Evaluation of potentiation of bromadiolone cake by ibuprofen and phenylbutazone. 
Qty of bait % 
Treatment Sex Body weight (g) consumed (mg/kg) Mortality Days to death 
Choice Test 
Bromadiolone cake + M 190.0±3.54 2.97±0.76 100 4.0±0.28 
Ibuprofen @ 80 mg/kg F 187.5±4.15 2.66±0.38 100 4.0±0.28 (Oral intubation) 
180.75±2.76 2.92±0.6 100 4.0±0.2 
Bromadiolone cake + M 110.0± 13.11 1.51±0.27 100 
Phenylbutazone @ 50 mg/kg F 71.25±9.42 1.34±0.19 100 Overnight (Subcutaneous) 
90.63± 10.59 1.25±0.23 100 
No Choice Test 
Bromadiolone cake + M 132.5± 18.58 2.16±0.03 100 4.3±0.21 
Ibuprofen @ 80 mg/kg F 142.5± 18.58 2.82±0.21 100 4.0±0.35 (Oral intubation) 
137.5± 13.26 2.49±0.12 100 4.3±0.28 
Bromadiolone cake + M 122.5± 15.26 1.61±0.21 100 
Phenylbutazone @ 50 mg/kg F 120.0± 15.41 1.85±0.19 100 Overnight (Subcutaneous) 
121.25± 10.85 1.73±0.15 100 
Table 4. Evaluation of potentiation of brodifacoum cakes by ibuprofen and phenylbutazone. 
Qty of bait % 
Treatment Sex Body weight (g) consumed (mg/kg) Mortality Days to death 
Choice Test 
Brodifacoum cake + M 138.0± 13.89 1.92±0.24 100 4.2±0.33 
Ibuprofen @ 80 mg/kg F 131.0± 12.52 2.32±0.67 100 3.6±0.36 (Oral intubation) 
134.5±9.42 2.12±0.14 100 3.9±0.26 
Brodifacoum cake + M 110.0± 17.74 0.28±0.03 100 
Phenylbutazone @ 50 mg/kg F 119.0± 13.52 0.26±0.05 100 Overnight (Subcutaneous) 
115.0±35.49 0.27±0.03 100 
No Choice Test 
Brodifacoum cake + M 94.0±9.53 0.71±0.13 100 4.4±0.22 
Ibuprofen @ 80 mg/kg F 109.0±23.81 0.72±0.16 100 4.4±0.22 (Oral intubation) 
101.5± 13.04 0.71±0.09 100 4.4±0.15 
Brodifacoum cake + M 142.5±9.88 0.13±0.02 100 
Phenylbutazone @ 50 mg/kg F 123.75±9.05 0.12±0.02 100 Overnight (Subcutaneous) 
133.13± 10.04 0.13±0.01 100 
of bait requirement and shorter duration to death in both 24 
and 48 hrs exposure to poison. (2) Both ibuprofen and 
phenylbutazone potentiated the action of bromadiolone and 
brodifacoum cakes. (3) The potentiation by phenylbutazone 
was higher than that of ibuprofen. (4) The potentiation of 
brodifacoum cakes by phenylbutazone was higher than that 
of bromadiolone cakes (Table 5). 
Potentiation of technical grade 
anticoagulants by the two drugs 
When rats were fed on sub-lethal doses of bromadiolone 
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(2 mg/kg) and brodifacoum (I mg/kg) by stomach intubation 
and potentiated with ibuprofen and phenylbutazone, deadl 
occured in comparatively shorter duration in ibuprofen treated 
rats but overnight in phenylbutamne injected subjects (Table 6). 
Duncan's Multiple Range test of experiments on poten-
tiation of technical grade bromadiolone and brodifacoum by 
ibuprofen and phenylbutazone indicated three significant 
points: (1) That the two drugs significantly potentiated the 
action of the two anticoagulants. (2) Between the two drugs, 
phenylbutazone was more potent as seen by overnight mor-
tality. (3) Brodifacoum was potentiated more than 
Table 5. DWlcan's analysis of the efficacy and potentiation of bromadiolone and brodifacoum cak~ by NSAIDs inRattus rattus. 
Bromadiolone 0.005% wax Brodifacoum 0.005% wax 
Sl. No. Rodenticide treatment Sex a b a b 
1 24 hrs exposure to wax cake M 8.0A 3.58A 6.6A 3.33A 
F 7.7A 3.75A 6.8A 3.28A 
2 48 hrs exposure to wax cake M 7.2AB 5.730 6.4A 4.26B 
F 6.2B 6.550 5.8A 4.SlB 
3 Potentiation with M 4.0C 2.97 AB 4.2B 0.71C 
ibuprofen @ 80 mg/kg F 4.0C 2.66ABC 3.6B 0.72C 
4 Potentiation with M 1.15 c 0.130 
phenylbutazone @ 50 mg/kg F 1.34 BC 0.120 
SD & (<lf} ±0.8 (20 df) ±0.52 (32 df) ±0.34 (24 df) ±0.17 (32 df) 
Legend: a - Days to death 
b - Quantity of bait consumed in mg/kg 
Note: The significance of the treatment is calculated through Duncan's Multiple Range test between means of the columns. The 
difference between the two means is significant if they are followed by a different alphabet (p<0.005). 
bromadiolone as seen by shorter duration to death (Table 7). 
Field evaluation of pot.entiated anticoagulants 
Table 6. Potentiation of technical grade bromadiolone and 
brodifacoum by ibuprofen and phenylbutazone. 
Brodifacoum cake pot.entiated with ibuprofen and 
phenylbutazone gave higher reduction of poultry shed rats 
than similarly pot.entiated bromadiolone (Table 2) and ~ 
tween the two NSAIDs, phenylbutazone was more effective. 
The same trend was seen when NSAIDs were added to poul-
try feed and exposed to rats along with the rodenticides (Table 
2). Thus the field trials when subjected to Duncan's Multiple 
Range test proved laboratory findings (Table 2). 
DISCUSSION 
With reports of development of resistance to brodi-
facoum and difenacoum (Rowe et al. 1981) it becomes im-
perative to evolve methods to overcome this problem. One 
such approach could be to pot.entiat.e the second generation 
anticoagulants by employing additives which can act as ab-
sorbers of vitamin K, capable of damaging capillaries, induc-
ing injuries and interfering with the mechanism of clotting. 
Activated clay, charcoal and carbon when combined with 
warfarin resulted in 88%, 75% and 63% mortality which was 
attributed to vitamin K absorption (Muktha Bai and Rao 
1979). Similarly L-hystidine combined with low dosages of 
warfarin caused 100% mortality of R .rattus due to haemorrh-
age caused by warfarin coupled with vasoconstrictor action 
and release of natural heparin from liver by L-hystidine 
(Muktha Bai and Rao 1979). The two non-steroidal anti-in-
flammatory drugs, phenylbutazone and ibuprofen potentiated 
the action of bromadiolone and brodifacoum in the present 
study by reducing time to death to overnight and reducing the 
lethal doses. The NSAIDs are known to interact with oral 
anticoagulants by a variety of mechanisms. Evidence is avail-
able to show that anticoagulants are affected by drugs which 
alter their absorption, protein binding or metabolism 
(Breckenbridge et al. 1978). Phenylbutaz.one displaces warfa-
rin from albumin and invariably leads to increased 
hypothrombinemia of anticoagulated patients (Koch-Weser 
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Treatment Sex Body weight 
A. BROMADIOLONE@ 2 mg/kg 
Bromadiolone only M 177.5±11.29 
(control) F 175.7± 14.89 
176.5±9.57 
Bromadiolone + M 149.0± 16.64 
Ibuprofen F 115.0±6.16 
132.0± 10.37 
Bromadiolone + M 138.0± 15.79 
Phenylbutazone F 139.0± 19.41 
138.5±12.51 
B. BROOIFACOUM@ 1 mg/kg 
Brodifacoum only M 112.0±7.67 
(control) F 123.0± 18.75 
117.5± 11.39 
Brodifacoum + M 111.0±9.84 
Ibuprofen F 101.0± 11.52 
106.0±7.74 
Brodifacoum + M 103.0± 10.03 
Phenylbutazone F 99.0±9.21 
107.0± 17.64 
Oaysof 
death 
6.0±1.41 
6.6±0.83 
6.38±0.75 
4.4±0.83 
4.4±0.46 
4.4±0.47 
Overnight 
4.8±0.49 
4.4±0.25 
4.6±0.37 
2.8±0.18 
2.2±0.33 
2.5±0.21 
Overnight 
Table 7. Duncan's analysis of potentiation of orally intubated bromadiolone and brodifacoum by anti-inflammatory drugs-
ibuprofen and phenylbutazone. 
SI 
No. 
Bromadiolone @ 2 mg/kg Brodifacoum @ 1 mg/kg 
Rodenticide 
Potentiation as agents 
I Phenylbutazone 
@50mg/kg 
2 Ibuprofen 
@80mg/kg 
3 Control 
(only anticoagulants) 
Sex 
M 
F 
M 
F 
M 
F 
Weight(g) 
138.00A 
139.00A 
143.00A 
115.00 A 
177.5 A 
175.7 A 
Days to dealh Weight(g) Days to dealh 
107.00A 
99.00A 
4.4A 111.00A 2.8A 
4.4A 101.00 A 2.2A 
6.0A 112.00A 4.8B 
6.6A 123.00A 4.4B 
SEm ±17.27 (24 df) ±0.82 (16 df) ±13.77 (24 df) ±0.38 (16 df) 
Remarks: Duncan's Multiple Range test conducted to check the significance of potentiation revealed that there is no dependence on 
the weight of the rat and phenylbutazone has a very high potentiating effect on both the rodenticides as it brings down the days to 
death to overnight. 
and Sellers 1971). It is also known to displace bolh warfarin 
isomers from plasma albumin in vivo and in vitro. In humans 
it is known to inhibit !he biotransformation of !he S isomer 
while stimulating !he elimination of R isomer. Since !he S 
isomer is 5 times more potent lhan R isomer, potentiation of 
warfarin induced hypolhrombinemia is reported to occur 
(Sellers 1978). 
A second way of potentiation of anticoagulants by 
NSA!Ds seems to be due to injuries caused. Many NSA!Ds 
including ibuprofen and phenylbutazone cause gastrointesti-
nal damage by way of ulceration and bleeding (Van 
kolfschoten et al. 1983). Of !he two drugs phenylbutazone 
was more potent ulcerogenic lhan ibuprofen (Diamentis et al. 
1980). The present observations of shorter duration to dealh 
at comparitively lower doses of anticoagulants when rats are 
fOO{mjected wilh ibuprofen and phenylbutazone supplements 
!he findings of Diamentis et al. (1980). 
The lhird way in which NSAIDs potentiate anticoagu-
lants may be by affecting wound healing. Healing of wounds 
has many phases such as granulation, collagenation, contrac-
tion, epilhelization and scar remodelling. All lhese phases 
excepting !he last are dependent on each olher and occur 
simultaneously. Many NSA!Ds are known to interfere wilh 
one event or olher. Diwan and Kulkarni (1986) observed 
ibuprofen and phenylbutazone depressing granulation, 
collagenation and initial phase of contraction of wounds. 
It may be concluded !hat bolh ibuprofen and phenyl-
butazone enhance the efficacy of bromadiolone and 
brodifacoum by affecting their binding, inducing gastric ul-
ceration, bleeding and fmally by interfering with natural 
healing of wounds. 
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